Scientific Freedom: The Elixir of Civilization
Braben argues that the modern peer review system and risk-averse funding structures are systematically killing transformative science.
His evidence is historical: he shows that most of the breakthroughs that created the modern world — from Planck's quantum theory to the discovery of DNA's structure — would fail today's grant application process because they were too speculative, too interdisciplinary, or too far from the consensus.
His proposal is to fund researchers rather than projects, giving proven scientists unconditional freedom to pursue whatever they find interesting.
The argument influenced Stripe's own approach to supporting basic research and resonates with anyone who has watched institutional incentives crush original thinking.
For product directors, Braben's analysis maps directly onto the tension between measurable quarterly outcomes and the exploratory work that produces genuine breakthroughs.
The book is a sustained argument for creating the conditions in which unexpected discoveries can happen.
Central argument
Braben argues that the institutional mechanisms governing scientific funding — particularly peer review and project-based grants — systematically select against the most transformative research by demanding legible hypotheses, disciplinary coherence, and predictable outcomes. His historical case is precise: discoveries such as Planck's quantum theory or the double helix structure of DNA would not survive a modern grant committee because they were too speculative or too removed from established consensus. His remedy is to fund researchers unconditionally rather than proposals, betting on the person's curiosity and track record rather than on a predetermined research agenda.
Critique
Braben's model implicitly assumes that the researchers most capable of transformative work are reliably identifiable in advance — that betting on the person can substitute for betting on the project. But the historical examples he marshals are largely legible only in retrospect, which raises a genuine selection problem: how do you identify the next Crick or Planck before the breakthrough, without some form of peer judgment that reintroduces the very gatekeeping he critiques? The proposal also sidesteps the accountability question — unconditional funding is politically and institutionally fragile, and the book offers limited guidance on how such a system sustains itself against the inevitable pressure to justify expenditure.
Why it matters for product
The structural argument maps directly onto the tension product directors face between OKR-driven quarterly cycles, which reward incremental and measurable progress, and the exploratory discovery work that produces genuine platform shifts or new user mental models — work that rarely fits a pre-approved hypothesis. Braben's case for funding researchers rather than projects has a concrete analogue in how product teams are staffed and tasked: persistent, empowered teams with stable membership and investigative latitude consistently outperform project-based squads assembled around predefined deliverables. For a CPO designing org structure, this book offers a rigorous intellectual justification for protecting a portion of team capacity from the metrics apparatus entirely.